Dexmedetomidine versus Propofol in reducing postoperative nausea and vomiting in gynecologic laparoscopic surgery
Author | Mansour Choubsaz | en |
Author | Mansour Rezaei | en |
Author | Aida Lahoorpour | en |
Author | Rasoul Mahdavi Jafari | en |
Issued Date | 2017-08-31 | en |
Abstract | Introduction: Post-Operative Nausea and Vomiting (PONV) occurs in 20%-30% of patients, and is the second most common complaints after pain. This unpleasant complication can lead to rare but serious medical complications such as aspiration of gastric contents, suture dehiscence, esophageal rupture, subcutaneous emphysema, or pneumothorax. Annual PONV-related health care costs reach several hundred million dollars. Many interventions have been done to control PONV, but complications of drug interactions limit the use of drugs. For example, Dropridol has been placed on the Black Box Warning because of the risk of cardiac arrhythmias. | en |
DOI | https://doi.org/10.22110/jkums.v21i2.3425 | en |
Keyword | Propofol | en |
Keyword | Dexmedetomidine | en |
Keyword | postoperative nausea and vomiting | en |
Keyword | visual analog scale | en |
Publisher | Brieflands | en |
Title | Dexmedetomidine versus Propofol in reducing postoperative nausea and vomiting in gynecologic laparoscopic surgery | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 69283.pdf
- Size:
- 381.08 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF